RXi Pharma Shares Spike to Session High, Now Up 14%, As Traders Circulating 'Project Presentation Day' Doc Showing Results For RXI-109 For Treatment To Reduce Formation Of Hypertrophic Dermal Scars
Benzinga Newsdesk